KAKhalid M. Al-Harbi

Khalid M. Al-Harbi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Khalid M. Al-Harbi has a total of 18 co-authors. Here are the top co-authors by number of shared publications:

  • Atiyeh M. Abdallah

    Department of Biomedical Sciences, College of Health Sciences, QU Health, Qatar University, Doha, Qatar

    2 shared publications
  • Abdulhadi Almazroea

    Department of Paediatrics College of Medicine, Taibah University Medina Medina Saudi Arabia

    1 shared publication
  • Adnan Aselan

    Pediatric Cardiologist, Madinah Maternity and Children Hospital, King Salman Medical City, Al Madinah Al Munawwarah, Saudi Arabia

    1 shared publication
  • Aisha Alnuzha

    Children & Maternity Hospital, Al-Madinah, Saudi Arabia

    1 shared publication
  • Ala Y. AlSamman

    Cardiogenetic Team, Department of Pediatrics, College of Medicine, Taibah University, Al-Madinah, Saudi Arabia

    1 shared publication
  • Alia M. Al-Balawi

    From the Cardiogenetics Unit (Al-Harbi, Abdelaziz, Al-Balawi, Abdallah), Center of Genetics and Inherited Diseases, Taibah University, the Department of Pediatric Cardiology (Almuzaini), Children and Maternity Hospital, the Department of Cardiology (Morsy), Madinah Cardiac Center, Al-Madinah, Kingdom of Saudi Arabia, and the Department of Microbiology and Immunology (Morsy, Abdelaziz), Sohag University, Sohag, Egypt

    1 shared publication

Latest Publications

  • Open Access

    Assessment of quality of life among parents of children with congenital heart disease using WHOQOL-BREF: a cross-sectional study from Northwest Saudi Arabia

    by Saad Khoshhal, Khaled Al-Harbi, Ibrahim Al-Mozainy, Saeed Al-Ghamdi, Adnan Aselan, Mohammad Allugmani, Sherif Salem, Dina El-Agamy, Hany Abo-Haded

    Background and aims: Health-related quality of life (HRQOL) has garnered increasing interest especially for health care providers and researchers. The study aims to evaluate the HRQOL in parents of congenital heart disease (CHD) children, and to clarify the effect of the disease severity on the outcome of the HRQOL perception. Also, to analyze the internal consistency of the Arabic version of the World Health Organization (WHO) QOL-BREEF tool in order to determine whether the tool had good validity for the target population. Methods: A cross-sectional study. The HRQOL perception was evaluated using WHOQOL-BREF questionnaire, and the internal consistency of the tool was tested using Cronbach’s alpha (α-C), Results: The study sample consisted of 200 individuals, 120 parents of CHD children, compared to 80 parents of children with minor illnesses (mean age of participating parents = 35.1 ± 9.8 years). While evaluating the HRQOL, the group of parents of children with minor illnesses had higher scores than the total group of parents of CHD children in all domains, indicating a better HRQOL. Class-IV subgroup of parents of CHD children showed the most significant lower total score of domains between all classes (44.47 ± 12, p < 0.001). With respect to the internal consistency of the WHOQOL-BREF, estimation of α-C values were 0.84 points for the group of parents of CHD children, and 0.87 for the group of parents of children with minor illnesses. Conclusions: This short-term study emphasized that, HRQOL scores among parents of CHD children are compromised, and the severity of their children illness significantly affect the total score of domains in their HRQOL perception. Furthermore, the tool showed to be practical and efficient to evaluate the QOL of parents of CHD children in our population in future researches.


  • IL10 Promoter Polymorphisms are Associated with Rheumatic Heart Disease in Saudi Arabian Patients

    by Atiyeh M. Abdallah, Aisha Alnuzha, Abdulhadi H. Al-Mazroea, Amr E. Eldardear, Ala Y. AlSamman, Yousef Almohammadi, Khalid M. Al-Harbi

    Rheumatic heart disease (RHD) is an inflammatory disease that develops following streptococcal infections. IL10 helps to balance immune responses to pathogens. IL10 polymorphisms have been associated with RHD, although results remain inconclusive. Our aim was to investigate the association between IL10 polymorphisms and RHD in Saudi Arabian patients. IL10 promoter polymorphisms (-1082A/G, -829C/T, and -592C/A) were genotyped in 118 RHD patients and 200 matched controls using the TaqMan allelic discrimination assay. There was a significant difference in IL10-1082 genotype frequency between patients and controls (p = 0.01). -1082G allele carriage (GG+GA vs AA) and the (-1082, -819, -592) GCC haplotype carriage were associated with an increased risk of RHD (p = 0.004, OR 2.1, 95 % CIs 1.7–3.4 and p = 0.004, OR 2, 95 % CIs 1.3–3.4, respectively). The ACC haplotype was associated with a decrease in RHD risk (p = 0.015, OR 0.6, 95 % CIs 0.4–0.9). IL10 promoter polymorphisms may play an important role in the development of RHD and provide an opportunity for therapeutic stratification.


  • Open Access

    Angiotensin-converting enzyme gene insertion/deletion polymorphism in Saudi patients with rheumatic heart disease

    by Khalid M. Al-Harbi, Ibrahim S. Almuzaini, Mohamed M. Morsy, Nada A. Abdelaziz, Alia M. Al-Balawi, Atiyeh M. Abdallah

    Angiotensin-converting enzyme gene insertion/deletion polymorphism in Saudi patients with rheumatic heart disease